周一,前期热门的美股散户抱团股出现松动,游戏驿站GME美股盘前一度涨10%,收跌超30%。AMC院线盘前涨近25%,最终收平。周一消息显示,游戏驿站空头头寸骤减。
媒体援...查看全文
chuminhua2020-12-23 12:04
12/22,BioCryst Pharmaceuticals表示,其广谱抗病毒药物galidesivir在一项针对中度至重度COVID-19住院成人的I期研究中显示出与安慰剂相比没有益处。另外,Kiniksa制药公司公布的II期数据显示,尽管有一些 "令人鼓舞的趋势",但与安慰剂相比,其研究药物GM-CSF受体-α单抗mavrilimumab未能...查看全文
淡泊2582020-12-12 15:30
$Biocryst医药(BCRX)$这个股票在5月份连续买了两次,都是小仓位操作,摊平平均成本在4.90,在冲6.29那波没有走,被迫持有,甚至小套,昨天8.10全部了结,回报率65%,还算不错,总结一下,时间持有有点长,没有抓住爆破点,题材有些小众,就是量价配合有点差强人意。查看全文
andrewmed2020-12-07 09:15
文章来源:“凯莱英药闻”微信公众号
BioCryst Pharmaceuticals宣布,FDA已批准每日一次口服ORLADEYO™(berotralstat)用于预防成人和12岁以上儿童患者遗传性血管性水肿(HAE)发作。
HAE是一种较为罕见的常染色体显性遗传病,临床上表现为反复发生的皮肤和黏膜水肿,水肿发生于呼吸道...查看全文
chuminhua2020-12-05 12:30
12/4,BioCryst Pharmaceuticals 宣布,FDA批准Orladeyo(berotralstat)用于预防12岁及以上成人和儿童患者的遗传性血管性水肿(HAE)发作。该公司指出,此次获批使该血浆kallikrein抑制剂成为美国在该适应症中授权的 "首个口服、每日一次 "的药物。该公司表示,该药此前名为BCX7353,按年...查看全文
CelineL2020-11-30 23:00
$Biocryst医药(BCRX)$ "Allergy Publishes Results from BioCryst’s APeX-J Trial of Oral, Once-Daily Berotralstat for the Prevention of HAE Attacks - met its primary endpoint of a reduction in the rate of HAE attacks...safe and generally well-tolerated in the trial..." 2...查看全文
智通财经APP获悉,2月2日(周二)美股盘前,WSB散户宣布“生物科技战”,受散户追捧的生物技术股票普涨。截至发稿,BioCryst制药(BCRX.US)涨10.57%,诺瓦瓦克斯医药 (NVAX.US)涨4.36%、德纳维制药(DVAX.US)涨10.03%、Inovio Pharmaceuti... 网页链接
Reddit大军向空头宣布“生物科技战”,若干被沽空生物科技股大幅上涨。Biocryst医药(BCRX)股价上涨逾40%,刷新2015年10月份以来盘中高位至11.98美元。 Reddit的WallStreetBets论坛上,有用户称该制药公司是“市场上被低... 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018715 Size: 9 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018720 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018725 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018728 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018733 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018705 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018708 Size: 7 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018711 Size: 8 KB 网页链接
$Biocryst医药(BCRX)$ 144 Report of proposed sale of securities Accession Number: 0001971857-24-000403 Act: 33 Size: 4 KB 网页链接